Crossref
GLP-1 receptor agonists as adjunct therapy in hidradenitis suppurativa: A hypothesis
Int. Journal of Clinical Pharmacology and Therapeutics · 01.05.2026 · 64 (05) · 283-284
DOI: 10.5414/cp204935 ↗Kurz gefasst
Fachartikel in der Zeitschrift Int. Journal of Clinical Pharmacology and Therapeutics, erschienen am 01.05.2026. Verfasst von Amir Feily.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Feily, A. (2026). GLP-1 receptor agonists as adjunct therapy in hidradenitis suppurativa: A hypothesis. Int. Journal of Clinical Pharmacology and Therapeutics, 64(05), 283-284. https://doi.org/10.5414/cp204935
Vancouver
Feily A. GLP-1 receptor agonists as adjunct therapy in hidradenitis suppurativa: A hypothesis. Int. Journal of Clinical Pharmacology and Therapeutics. 2026;64(05):283-284. doi:10.5414/cp204935
BibTeX
@article{Feily2026,
author = {Feily, Amir},
title = {GLP-1 receptor agonists as adjunct therapy in hidradenitis suppurativa: A hypothesis},
journal = {Int. Journal of Clinical Pharmacology and Therapeutics},
year = {2026},
volume = {64},
number = {05},
pages = {283--284},
doi = {10.5414/cp204935}
}
EUVIMED